These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8851505)

  • 21. Cyclosporine A and purinergic receptors in rat kidney.
    Halimi G; Sampol J; Clot-Faybesse O; Mercier L; Devaux C; Berland Y; Dussol B; Rochat H; Guieu R
    Life Sci; 1999; 65(26):2801-13. PubMed ID: 10622269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of felodipine on renal function and blood pressure in cyclosporin-treated renal transplant recipients during the first three months after transplantation.
    Madsen JK; Sørensen SS; Hansen HE; Pedersen EB
    Nephrol Dial Transplant; 1998 Sep; 13(9):2327-34. PubMed ID: 9761517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular and renal effects of blocking A1 adenosine receptors.
    Kuan CJ; Herzer WA; Jackson EK
    J Cardiovasc Pharmacol; 1993 May; 21(5):822-8. PubMed ID: 7685455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term cyclosporin A nephrotoxicity in the rat. Evaluation of a morphological scoring system and of co-treatment with isradipine.
    Starklint H; Hansen HV; Kemp M; Leyssac PP; Kemp E; Dieperink H
    APMIS; 1994 May; 102(5):347-55. PubMed ID: 8024736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction of ciclosporin and tacrolimus nephrotoxicity by plant polyphenols.
    Zhong Z; Connor HD; Li X; Mason RP; Forman DT; Lemasters JJ; Thurman RG
    J Pharm Pharmacol; 2006 Nov; 58(11):1533-43. PubMed ID: 17132217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An experimental paradigm for investigating the role of endogenous adenosine/A1 receptor interactions in vivo.
    Kuan CJ; Herzer WA; Jackson EK
    J Pharmacol Exp Ther; 1992 Nov; 263(2):657-62. PubMed ID: 1432696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serial changes in blood pressure, renal function, endothelin and lipoprotein (a) during the first 9 days of cyclosporin therapy in males.
    Sturrock ND; Lang CC; MacFarlane LJ; Dockrell ME; Ryan M; Webb DJ; Struthers AD
    J Hypertens; 1995 Jun; 13(6):667-73. PubMed ID: 7594425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postoperative intravenous infusion of alprostadil (PGE1) does not improve renal function in hepatic transplant recipients.
    Manasia AR; Leibowitz AB; Miller CM; Silverstein JH; Schwartz M; Delgiudice R; Vallabhajosula S; Oropello JM; Benjamin E
    J Am Coll Surg; 1996 Apr; 182(4):347-52. PubMed ID: 8605558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal injury induced by long-term administration of cyclosporin A to rats.
    Bertani T; Perico N; Abbate M; Battaglia C; Remuzzi G
    Am J Pathol; 1987 Jun; 127(3):569-79. PubMed ID: 3591904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxic effect of concomitant administration of cyclosporin A and acyclovir on renal function and morphology in rats.
    Hannemann J; Wunderle W; Yousif T; Krüger S; Baumann K
    Arch Toxicol; 1997; 71(9):556-62. PubMed ID: 9285038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An orally active adenosine A1 receptor antagonist, FK838, increases renal excretion and maintains glomerular filtration rate in furosemide-resistant rats.
    Schnackenberg CG; Merz E; Brooks DP
    Br J Pharmacol; 2003 Aug; 139(8):1383-8. PubMed ID: 12922924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphodiesterase type 5 inhibition attenuates cyclosporine A induced nephrotoxicity in mice.
    Essiz D; Sozmen M; Sudagidan M; Devrim AK
    Biotech Histochem; 2015 Apr; 90(3):167-78. PubMed ID: 25420893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo effect of the natural antioxidant hydroxytyrosol on cyclosporine nephrotoxicity in rats.
    Capasso G; Di Gennaro CI; Della Ragione F; Manna C; Ciarcia R; Florio S; Perna A; Pollastro RM; Damiano S; Mazzoni O; Galletti P; Zappia V
    Nephrol Dial Transplant; 2008 Apr; 23(4):1186-95. PubMed ID: 18057067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenosine receptor antagonism in acute tacrolimus toxicity.
    McLaughlin GE; Alva MD; Egea M
    Nephrol Dial Transplant; 2006 Jul; 21(7):1961-5. PubMed ID: 16522656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of nifedipine on cyclosporine A-induced nephrotoxicity, urinary endothelin excretion and renal endothelin receptor number.
    Brooks DP; Ohlstein EH; Contino LC; Storer B; Pullen M; Caltabiano M; Nambi P
    Eur J Pharmacol; 1991 Feb; 194(1):115-7. PubMed ID: 1647960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A role for leukotrienes in cyclosporine nephrotoxicity.
    Butterly DW; Spurney RF; Ruiz P; Griffiths R; Albrightson C; Coffman TM
    Kidney Int; 2000 Jun; 57(6):2586-93. PubMed ID: 10844628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of nitric oxide modulation on TGF-beta1 and matrix proteins in chronic cyclosporine nephrotoxicity.
    Shihab FS; Yi H; Bennett WM; Andoh TF
    Kidney Int; 2000 Sep; 58(3):1174-85. PubMed ID: 10972680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of cyclosporin A on glomerular filtration rate in children with minimal change nephrotic syndrome.
    Hulton SA; Jadresic L; Shah V; Trompeter RS; Dillon MJ; Barratt TM
    Pediatr Nephrol; 1994 Aug; 8(4):404-7. PubMed ID: 7947024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of enalapril on experimental cyclosporin A nephrotoxicity.
    Anarat A; Noyan A; Gonlusen G; Duman N; Tuncer D
    Pediatr Nephrol; 1996 Oct; 10(5):616-20. PubMed ID: 8897568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An underlying role for hepatobiliary dysfunction in cyclosporine A nephrotoxicity.
    Aleo MD; Doshna CM; Fritz CA
    Toxicol Appl Pharmacol; 2008 Jul; 230(1):126-34. PubMed ID: 18407308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.